{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:24:57Z","timestamp":1794018297602,"version":"4.8.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.humpath.2026.106200","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T14:34:24Z","timestamp":1782052464000},"page":"106200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Artificial intelligence-assisted screening for NTRK fusion-positive salivary gland tumors: A novel digital pathology workflow"],"prefix":"10.1016","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6422-4033","authenticated-orcid":false,"given":"Ryutaro","family":"Onaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Sakashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Komura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genichiro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumpei","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106200_bib1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s12105-022-01459-0","article-title":"Distribution and frequency of salivary gland tumours: an international multicenter study","volume":"16","author":"Alsanie","year":"2022","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2026.106200_bib2","series-title":"World Health Organization classification of tumours","article-title":"Head and neck tumours part A","year":"2024"},{"key":"10.1016\/j.humpath.2026.106200_bib3","series-title":"National comprehensive cancer network clinical practice guidelines in oncology, head and neck cancers","year":"2025"},{"key":"10.1016\/j.humpath.2026.106200_bib4","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.21.00449","article-title":"Management of salivary gland malignancy: ASCO Guideline","volume":"39","author":"Geiger","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2026.106200_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100602","article-title":"Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"7","author":"van Herpen","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.humpath.2026.106200_bib6","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/1078-0432.CCR-21-3597","article-title":"Updated integrated analysis of the efficacy and safety of entrectinib in patients with NTRK fusion-positive solid tumors","volume":"28","author":"Demetri","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2026.106200_bib7","article-title":"Larotrectinib treatment for patients with TRK fusion-positive salivary gland cancers","author":"Le","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.humpath.2026.106200_bib8","doi-asserted-by":"crossref","first-page":"S787","DOI":"10.1016\/j.annonc.2023.09.2405","article-title":"1372P Repotrectinib in patients (pts) with NTRK fusion-positive (NTRK+) advanced solid tumors, including NSCLC: update from the phase I\/II TRIDENT-1 trial","volume":"34","author":"Solomon","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2026.106200_bib9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","article-title":"Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity","volume":"34","author":"Skalova","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106200_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","article-title":"NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls","volume":"33","author":"Solomon","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106200_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41698-021-00206-y","article-title":"Genomic context of NTRK1\/2\/3 fusion-positive tumours from a large real-world population","volume":"5","author":"Westphalen","year":"2021","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.humpath.2026.106200_bib12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/jclinpath-2018-205679","article-title":"Testing algorithm for identification of patients with TRK fusion cancer","volume":"72","author":"Penault-Llorca","year":"2019","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106200_bib13","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/annonc\/mdz204","article-title":"ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research","volume":"30","author":"Marchio","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2026.106200_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/curroncol28010053","article-title":"Canadian consensus for biomarker testing and treatment of TRK fusion cancer in adults","volume":"28","author":"Bebb","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.humpath.2026.106200_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.annonc.2020.03.299","article-title":"JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions","volume":"31","author":"Yoshino","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2026.106200_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41379-018-0118-3","article-title":"Molecular characterization of cancers with NTRK gene fusions","volume":"32","author":"Gatalica","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106200_bib17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/his.14884","article-title":"A systematic comparison of pan-trk immunohistochemistry assays among multiple cancer types","volume":"82","author":"Haberecker","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106200_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejca.2022.06.030","article-title":"The sensitivity of pan-TRK immunohistochemistry in solid tumours: a meta-analysis","volume":"173","author":"Hondelink","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2026.106200_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814203","article-title":"Cost-efficient detection of NTRK1\/2\/3 gene fusions: Single-center analysis of 8075 tumor samples","volume":"24","author":"Romanko","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.humpath.2026.106200_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40291-022-00617-y","article-title":"Prevalence of NTRK fusions in Canadian solid tumour cancer patients","volume":"27","author":"Silvertown","year":"2023","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.humpath.2026.106200_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41746-024-01106-8","article-title":"Artificial intelligence in digital pathology: a systematic review and meta-analysis of diagnostic test accuracy","volume":"7","author":"McGenity","year":"2024","journal-title":"npj Digit Med"},{"key":"10.1016\/j.humpath.2026.106200_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110424","article-title":"Universal encoding of pan-cancer histology by deep texture representations","volume":"38","author":"Komura","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.humpath.2026.106200_bib23","article-title":"Benchmarking deep learning-based image retrieval of oral tumor histology","volume":"16","author":"Herdiantoputri","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.humpath.2026.106200_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/joim.13030","article-title":"Artificial intelligence as the next step towards precision pathology","volume":"288","author":"Acs","year":"2020","journal-title":"J Intern Med"},{"key":"10.1016\/j.humpath.2026.106200_bib25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41571-019-0252-y","article-title":"Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology","volume":"16","author":"Bera","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.humpath.2026.106200_bib26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/his.13845","article-title":"Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma","volume":"75","author":"Hung","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106200_bib27","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/PAS.0000000000000911","article-title":"Pan-Trk Immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions","volume":"41","author":"Hechtman","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106200_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13000-023-01426-5","article-title":"Validation and interpretation of Pan-TRK immunohistochemistry: a practical approach and challenges with interpretation","volume":"19","author":"Karakas","year":"2024","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2026.106200_bib29","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jval.2021.11.1359","article-title":"Appraising the costs of genomic testing for histology-independent technologies: an illustrative example for NTRK fusions","volume":"25","author":"Beresford","year":"2022","journal-title":"Value Health"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726001693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726001693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:42:58Z","timestamp":1794015778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726001693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":29,"alternative-id":["S0046817726001693"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106200","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial intelligence-assisted screening for NTRK fusion-positive salivary gland tumors: A novel digital pathology workflow","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106200"}}